Cargando…
P952: PROGNOSTIC SIGNIFICANCE OF DYNAMIC CHANGE OF MAGE-C1/CT7 IN MULTIPLE MYELOMA: TEN YEAR EXPERIENCE FROM A SINGLE CENTER
Autores principales: | Dou, Xuelin, Wang, Fengrong, Chen, Huan, Chen, Yao, Wen, Lei, Liu, Yang, Wang, Shasha, Duan, Wenbing, Ruan, Guorui, Zhao, Xiaosu, Liu, Kaiyan, Huang, Xiaojun, Lu, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431349/ http://dx.doi.org/10.1097/01.HS9.0000970712.49233.dc |
Ejemplares similares
-
Is t(11;14)(q13;q32) good or bad for newly diagnosed multiple myeloma?
por: Liu, Yang, et al.
Publicado: (2023) -
P952: THE ROLE OF AGE IN THE LONG-TERM TREATMENT OF MULTIPLE MYELOMA - A LONGITUDINAL ANALYSIS OF REGULAR CARE DATA
por: Steinmetz, H. T., et al.
Publicado: (2022) -
POS-952 COVID-19 and impact on patients and staff in Tanker Foundation
por: Kumaresan, M., et al.
Publicado: (2022) -
Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma
por: Curioni-Fontecedro, A., et al.
Publicado: (2015) -
Cancer/Testis Antigen MAGE-C1/CT7: New Target for Multiple Myeloma Therapy
por: de Carvalho, Fabricio, et al.
Publicado: (2012)